Cardiac stimulation during ritodrine hydrochloride tocolytic therapy

Area of Science:

• Cardiology
• Maternal-Fetal Medicine
• Pharmacology

Background:

• Tocolytic therapy is used to inhibit premature labor.
• Ritodrine hydrochloride is a common tocolytic agent.
• Understanding its effects on maternal cardiovascular function is crucial.

Purpose of the Study:

• To evaluate the impact of ritodrine hydrochloride on maternal left ventricular size and performance during pregnancy.
• To assess the inotropic and chronotropic effects of ritodrine on the maternal heart.

Main Methods:

• M-mode echocardiography was utilized to monitor cardiac parameters.
• Measurements included left ventricular dimensions, stroke volume, ejection fraction, and cardiac output.
• Systemic arterial pressure and heart rate were also recorded.

Main Results:

• Ritodrine therapy led to increased heart rate, stroke volume, ejection fraction, and cardiac output.
• Left ventricular end-diastolic dimension and systemic arterial pressure remained unchanged.
• Left ventricular velocity of circumferential fiber shortening showed significant augmentation.

Conclusions:

• Ritodrine hydrochloride exhibits potent positive inotropic and chronotropic effects on the maternal heart.
• These cardiovascular effects necessitate careful consideration.
• Ritodrine tocolytic therapy should be administered cautiously in pregnant patients with underlying heart disease.